Market revenue in 2022 | USD 2,800.7 million |
Market revenue in 2030 | USD 3,762.2 million |
Growth rate | 3.8% (CAGR from 2022 to 2030) |
Largest segment | Open angle glaucoma |
Fastest growing segment | Open Angle Glaucoma |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Open Angle Glaucoma, Angle Closure Glaucoma, Others Disease Type |
Key market players worldwide | Pfizer Inc, Santen Pharmaceutical Co Ltd, Novartis AG ADR, Alcon Inc, Akron Biotechnology, AbbVie Inc, Bausch & Lomb Corp, Teva Pharmaceutical Industries Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glaucoma market , 2030 will help companies and investors design strategic landscapes.
Open angle glaucoma was the largest segment with a revenue share of 76.61% in 2022. Horizon Databook has segmented the U.S. glaucoma market , 2030 based on open angle glaucoma, angle closure glaucoma, others disease type covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. glaucoma market , 2030, including forecasts for subscribers. This country databook contains high-level insights into U.S. glaucoma market , 2030 from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account